Clinical Trial Update: Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated the efficacy and safety of ciclesonide HFA nasal aerosol for seasonal allergic rhinitis; the study was completed and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• ciclesonide HFA nasal aerosol (ciclesonide)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2012-06-08